Please select the option that best describes you:
Topics:
Internal Medicine • Rheumatology • Vasculitis • Rituximab • Cyclophosphamide • ANCA Vasculitis • Allergy & Immunology • Pulmonology • Dermatology • Eosinophilic Disorders
Which ANCA vasculitis patients are better candidates for cyclophosphamide rather than rituximab?
Answer from: at Community Practice
Both can be used for induction in GPA/MPA vasculitis. I would use rituximab (RTX) if the patient has previously been treated with cyclophosphamide (CYC) and developed a relapse/flare and in patients who are young and with fertility concerns. In GPA/MPA, I tend to use RTX most of the time for inducti...
Sign in or Register to read more
Answer from: at Community Practice
Another controversial issue! I have not seen convincing evidence that the effect of cyclophosphamide in ANCA-associated vasculitis is “faster” than the effect of rituximab; there are data from RAVE of equal time to remission for these two treatments. Remember that treatment trials of AAV...